These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 36565605)

  • 1. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the GheOP
    Foubert K; Muylaert P; Mehuys E; Somers A; Petrovic M; Boussery K
    Acta Clin Belg; 2020 Dec; 75(6):388-396. PubMed ID: 31241000
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
    Balsom C; Pittman N; King R; Kelly D
    Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
    Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
    Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stakeholder perspectives on pharmacist involvement in a memory clinic to review patients' medication management and assist with deprescribing.
    Cross AJ; Le VJ; George J; Woodward MC; Elliott RA
    Res Social Adm Pharm; 2020 May; 16(5):681-688. PubMed ID: 31405811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial.
    Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Kripalani S; Mixon AS; Simmons SF
    JAMA Intern Med; 2023 Mar; 183(3):223-231. PubMed ID: 36745422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of interprofessional quality circles on deprescribing in Swiss nursing homes: an observational study.
    Mena S; Moullin JC; Schneider M; Niquille A
    BMC Geriatr; 2023 Oct; 23(1):620. PubMed ID: 37789286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacist-led pilot program to facilitate deprescribing in a primary care clinic.
    Clark CM; LaValley SA; Singh R; Mustafa E; Monte SV; Wahler RG
    J Am Pharm Assoc (2003); 2020; 60(1):105-111. PubMed ID: 31690514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
    Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
    J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial.
    Cateau D; Ballabeni P; Niquille A
    BMC Geriatr; 2021 Nov; 21(1):655. PubMed ID: 34798826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' attitudes towards interprofessional collaboration to optimise medication use in older patients in Switzerland: a survey study.
    Lüthold RV; Cateau D; Jenkinson SP; Streit S; Jungo KT
    BMC Health Serv Res; 2024 Jul; 24(1):849. PubMed ID: 39061037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of on-site pharmacist in residential aged care facilities: findings from the PiRACF study.
    Haider I; Kosari S; Naunton M; Koerner J; Dale M; Nizamani S; Davey R
    J Pharm Policy Pract; 2023 Jul; 16(1):82. PubMed ID: 37400921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.
    Bolmsjö BB; Palagyi A; Keay L; Potter J; Lindley RI
    BMC Fam Pract; 2016 Nov; 17(1):152. PubMed ID: 27814691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.
    Jovevski JJ; Smith CR; Roberts JL; Dev S; Iloabuchi TC; Gruber EA; Williams MJ; Slaven JE; Mitchell AM
    Acad Emerg Med; 2023 Apr; 30(4):410-419. PubMed ID: 36794336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist-led medication review in a residential in-reach service leads to deprescribing.
    Hui JH; Parikh S; Kouladjian O'Donnell L; Mcinerney B; Dillon L; Poojary S; Crabtree A
    Australas J Ageing; 2023 Dec; 42(4):675-682. PubMed ID: 37198738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.